These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 29750331

  • 1. Salivary-gland-protective regulatory T-cell dysfunction underlies female-specific sialadenitis in the non-obese diabetic mouse model of Sjögren syndrome.
    Barr JY, Wang X, Kreiger PA, Lieberman SM.
    Immunology; 2018 Oct; 155(2):225-237. PubMed ID: 29750331
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Suppression of age-related salivary gland autoimmunity by glycosylation-dependent galectin-1-driven immune inhibitory circuits.
    Martínez Allo VC, Hauk V, Sarbia N, Pinto NA, Croci DO, Dalotto-Moreno T, Morales RM, Gatto SG, Manselle Cocco MN, Stupirski JC, Deladoey Á, Maronna E, Marcaida P, Durigan V, Secco A, Mamani M, Dos Santos A, Catalán Pellet A, Pérez Leiros C, Rabinovich GA, Toscano MA.
    Proc Natl Acad Sci U S A; 2020 Mar 24; 117(12):6630-6639. PubMed ID: 32161138
    [Abstract] [Full Text] [Related]

  • 4. CD8 T cells contribute to lacrimal gland pathology in the nonobese diabetic mouse model of Sjögren syndrome.
    Barr JY, Wang X, Meyerholz DK, Lieberman SM.
    Immunol Cell Biol; 2017 Sep 24; 95(8):684-694. PubMed ID: 28465508
    [Abstract] [Full Text] [Related]

  • 5. Type I Interferon Signaling Is Required for Dacryoadenitis in the Nonobese Diabetic Mouse Model of Sjögren Syndrome.
    Chaly Y, Barr JY, Sullivan DA, Thomas HE, Brodnicki TC, Lieberman SM.
    Int J Mol Sci; 2018 Oct 20; 19(10):. PubMed ID: 30347820
    [Abstract] [Full Text] [Related]

  • 6. Agonist-induced 4-1BB activation prevents the development of Sjӧgren's syndrome-like sialadenitis in non-obese diabetic mice.
    Zhou J, You BR, Yu Q.
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar 01; 1866(3):165605. PubMed ID: 31740402
    [Abstract] [Full Text] [Related]

  • 7. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
    Kim D, Kim JY, Jun HS.
    Oncotarget; 2016 Dec 06; 7(49):80298-80312. PubMed ID: 27880731
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome.
    Voynova E, Lefebvre F, Qadri A, Muller S.
    J Autoimmun; 2020 Mar 06; 108():102418. PubMed ID: 32029330
    [Abstract] [Full Text] [Related]

  • 10. Reciprocal relation between GADD153 and Del-1 in regulation of salivary gland inflammation in Sjögren syndrome.
    Baban B, Liu JY, Abdelsayed R, Mozaffari MS.
    Exp Mol Pathol; 2013 Dec 06; 95(3):288-97. PubMed ID: 24060278
    [Abstract] [Full Text] [Related]

  • 11. B7-H4 Inhibits the Development of Primary Sjögren's Syndrome by Regulating Treg Differentiation in NOD/Ltj Mice.
    Zheng X, Wang Q, Yuan X, Zhou Y, Chu H, Wang G, Li X, Wang Y, Wei L, Wang L, Li X.
    J Immunol Res; 2020 Dec 06; 2020():4896727. PubMed ID: 33062721
    [Abstract] [Full Text] [Related]

  • 12. Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome.
    Yin H, Nguyen CQ, Samuni Y, Uede T, Peck AB, Chiorini JA.
    Arthritis Res Ther; 2012 Feb 27; 14(1):R40. PubMed ID: 22369699
    [Abstract] [Full Text] [Related]

  • 13. Non-depleting anti-CD4 antibody not only prevents onset but resolves sialadenitis in NOD mice.
    Thompson C, Jacobsen H, Pomeranz Krummel D, Nagai K, Cooke A.
    Autoimmunity; 2004 Dec 27; 37(8):549-54. PubMed ID: 15763917
    [Abstract] [Full Text] [Related]

  • 14. Plasmacytoid dendritic cells promote the pathogenesis of Sjögren's syndrome.
    Zhou J, Zhang X, Yu Q.
    Biochim Biophys Acta Mol Basis Dis; 2022 Feb 01; 1868(2):166302. PubMed ID: 34780913
    [Abstract] [Full Text] [Related]

  • 15. Altered characteristics of regulatory T cells in target tissues of Sjögren's syndrome in murine models.
    Zhou J, Felix FA, Jiang Y, Li D, Kim MC, Jang D, Cha S, Yu Q.
    Mol Immunol; 2024 Oct 01; 174():47-56. PubMed ID: 39197397
    [Abstract] [Full Text] [Related]

  • 16. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
    Kim JW, Kim SM, Park JS, Hwang SH, Choi J, Jung KA, Ryu JG, Lee SY, Kwok SK, Cho ML, Park SH.
    Arthritis Res Ther; 2019 Jun 04; 21(1):136. PubMed ID: 31164166
    [Abstract] [Full Text] [Related]

  • 17. Transient depletion of CD4+ CD25+ regulatory T cells results in multiple autoimmune diseases in wild-type and B-cell-deficient NOD mice.
    Ellis JS, Wan X, Braley-Mullen H.
    Immunology; 2013 Jun 04; 139(2):179-86. PubMed ID: 23293979
    [Abstract] [Full Text] [Related]

  • 18. Pathogenic role of endogenous TNF-α in the development of Sjögren's-like sialadenitis and secretory dysfunction in non-obese diabetic mice.
    Zhou J, Kawai T, Yu Q.
    Lab Invest; 2017 Apr 04; 97(4):458-467. PubMed ID: 28067896
    [Abstract] [Full Text] [Related]

  • 19. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
    Humphreys-Beher MG, Yamachika S, Yamamoto H, Maeda N, Nakagawa Y, Peck AB, Robinson CP.
    Eur J Morphol; 1998 Aug 04; 36 Suppl():247-51. PubMed ID: 9825931
    [Abstract] [Full Text] [Related]

  • 20. Different lymphoproliferative disorders in different salivary glands of primary Sjögren syndrome.
    Zheng L, Yu C, Yang C.
    J Craniofac Surg; 2013 Aug 04; 24(5):e462-5. PubMed ID: 24036814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.